Effects of Spermidine-Rich Rice Germ Extract Supplement on Biomarkers of Healthy Aging and Autophagy-Proof-of-Concept Pilot Study.
Gene Bruno, Michael La Monica, Tim N Ziegenfuss
https://pubmed.ncbi.nlm.nih.gov/40862848/Actively Recruiting
Led by Nutraland USA, Inc. · Updated on 2026-06-30
70
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a dietary supplement called Miricell to see if it supports cellular health and healthy aging in adults aged 40 to 70. The trial aims to learn if Miricell improves autophagy, the bodys natural process for recycling damaged cells, and whether it benefits brain health, metabolic health, and visible signs of aging. The study also monitors any medical problems participants may experience while taking Miricell compared to a placebo. Participants are randomly assigned to take either one capsule of Miricell, which contains a standardized spermidine ingredient, or a placebo capsule each day for 12 weeks. Both capsules look identical to keep the study double-blind. Participants follow strict dietary guidelines to maintain consistent intake of polyamine-rich foods and other lifestyle habits to minimize variables. They take the capsules with a morning meal and follow specific fasting and diet instructions before scheduled lab visits. During the study, participants visit the research clinic four times for checkups and tests. They complete memory and thinking assessments, track daily physical activity, and provide blood samples at baseline, week 6, and week 12 to measure markers like serum Beclin-1 and ULK1 concentrations. Safety is closely monitored, with adverse events evaluated by medical staff. The total participation lasts for 12 weeks, with continuous monitoring to ensure protocol compliance and data quality.
CONDITIONS
Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy
M
Michael B La Monica, Ph.D., CSCS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nutraland USA, Inc.
Lead Sponsor
The Center for Applied Health Sciences, LLC
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Miricell™ (spermidine 3.3 mg/day) | Placebo |
|---|---|---|
| What it is | Daily supplementation with Miricell™ spermidine (3.3 mg/day) provided as an opaque capsule taken each morning with a meal. | Daily ingestion of a matching placebo capsule (microcrystalline cellulose) taken each morning with a meal. |
| Role in the trial | Active investigational supplement arm to test effects on biomarkers of autophagy and healthy aging. | Control arm acting as placebo comparator for assessing biomarker changes. |
| Primary use | Studied for its ability to improve biomarkers of autophagy (Beclin‑1, ULK1), neuroprotection (BDNF), and cardiometabolic markers in healthy adults. | Serves as a baseline comparison to evaluate any changes in the same biomarkers without active supplementation. |
| How it is given or performed | One opaque Miricell™ capsule taken orally once daily in the morning with a meal. | One matching opaque placebo capsule taken orally once daily in the morning with a meal. |
| Important limitations | Pilot evidence derives from small, single‑blind or early‑phase studies; long‑term effects on clinical outcomes and safety remain unknown. | Placebo arm reflects no active intervention but does not indicate what standard supplement use outside the trial might be. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants take one capsule of either Miricell or a placebo daily with a morning meal for 12 weeks while following dietary and lifestyle instructions.
4 clinic visits for checkups and tests
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Gene Bruno, Michael La Monica, Tim N Ziegenfuss
https://pubmed.ncbi.nlm.nih.gov/40862848/Nutraland USA, Inc.
Lead Sponsor
The Center for Applied Health Sciences, LLC
Collaborating Sponsor